Abbott Laboratories' Q1 Adjusted Earnings, Revenue Rise; Reaffirms 2025 Guidance

MT Newswires Live

Apr 16, 2025

Abbott Laboratories (ABT) reported Q1 adjusted earnings Wednesday of $1.09 per diluted share, up from $0.98 a year earlier.

Analysts polled by FactSet expected $1.07.

Revenue for the quarter ended March 31 was $10.36 billion compared with $9.96 billion a year earlier.

Analysts surveyed by FactSet expected $10.41 billion.

For Q2, the company said it expects adjusted diluted earnings per share of $1.23 to $1.27. Analysts surveyed by FactSet expect $1.25.

Abbott reaffirmed its 2025 adjusted diluted earnings per share guidance of $5.05 to $5.25. Analysts surveyed by FactSet expect $5.15. The company also reiterated its annual organic sales growth to be 7.5% to 8.5%. Analysts polled by FactSet expect $44.40 billion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2527021841"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527021841\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2527021841?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-16 19:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527021841","market":"nz","top_or_hot":-1,"title":"Abbott Laboratories' Q1 Adjusted Earnings, Revenue Rise; Reaffirms 2025 Guidance","media":"MT Newswires Live","content":"<html><body><p> Abbott Laboratories (ABT) reported Q1 adjusted earnings Wednesday of $1.09 per diluted share, up from $0.98 a year earlier.</p><p>Analysts polled by FactSet expected $1.07.</p><p>Revenue for the quarter ended March 31 was $10.36 billion compared with $9.96 billion a year earlier.</p><p>Analysts surveyed by FactSet expected $10.41 billion.</p><p>For Q2, the company said it expects adjusted diluted earnings per share of $1.23 to $1.27. Analysts surveyed by FactSet expect $1.25.</p><p>Abbott reaffirmed its 2025 adjusted diluted earnings per share guidance of $5.05 to $5.25. Analysts surveyed by FactSet expect $5.15. The company also reiterated its annual organic sales growth to be 7.5% to 8.5%. Analysts polled by FactSet expect $44.40 billion.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Abbott Laboratories' Q1 Adjusted Earnings, Revenue Rise; Reaffirms 2025 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAbbott Laboratories' Q1 Adjusted Earnings, Revenue Rise; Reaffirms 2025 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-16 19:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Abbott Laboratories (ABT) reported Q1 adjusted earnings Wednesday of $1.09 per diluted share, up from $0.98 a year earlier.</p><p>Analysts polled by FactSet expected $1.07.</p><p>Revenue for the quarter ended March 31 was $10.36 billion compared with $9.96 billion a year earlier.</p><p>Analysts surveyed by FactSet expected $10.41 billion.</p><p>For Q2, the company said it expects adjusted diluted earnings per share of $1.23 to $1.27. Analysts surveyed by FactSet expect $1.25.</p><p>Abbott reaffirmed its 2025 adjusted diluted earnings per share guidance of $5.05 to $5.25. Analysts surveyed by FactSet expect $5.15. The company also reiterated its annual organic sales growth to be 7.5% to 8.5%. Analysts polled by FactSet expect $44.40 billion.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABT","symbol_name":"雅培","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2527021841","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527021841","pubTimestamp":1744804227,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Abbott Laboratories  reported Q1 adjusted earnings Wednesday of $1.09 per diluted share, up from $0.98 a year earlier.Analysts polled by FactSet expected $1.07.Revenue for the quarter ended March 31 was $10.36 billion compared with $9.96 billion a year earlier.Analysts surveyed by FactSet expected $10.41 billion.For Q2, the company said it expects adjusted diluted earnings per share of $1.23 to $1.27. Analysts surveyed by FactSet expect $1.25.Abbott reaffirmed its 2025 adjusted diluted earnings per share guidance of $5.05 to $5.25. Analysts surveyed by FactSet expect $5.15. The company also reiterated its annual organic sales growth to be 7.5% to 8.5%. Analysts polled by FactSet expect $44.40 billion.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ABT":"雅培"},"translate_title":"雅培实验室第一季度调整后盈利、收入增长；重申2025年指导","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABT":1},"content_text":"Abbott Laboratories (ABT) reported Q1 adjusted earnings Wednesday of $1.09 per diluted share, up from $0.98 a year earlier.Analysts polled by FactSet expected $1.07.Revenue for the quarter ended March 31 was $10.36 billion compared with $9.96 billion a year earlier.Analysts surveyed by FactSet expected $10.41 billion.For Q2, the company said it expects adjusted diluted earnings per share of $1.23 to $1.27. Analysts surveyed by FactSet expect $1.25.Abbott reaffirmed its 2025 adjusted diluted earnings per share guidance of $5.05 to $5.25. Analysts surveyed by FactSet expect $5.15. The company also reiterated its annual organic sales growth to be 7.5% to 8.5%. Analysts polled by FactSet expect $44.40 billion.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}